Page last updated: 2024-08-17

aspartic acid and indazoles

aspartic acid has been researched along with indazoles in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (42.86)18.2507
2000's1 (14.29)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cupak, K; Kosanović, M1
Dunn, D; Farnworth, M; Gyte, A; Lock, EA; Moore, RB; Simpson, MG; Widdowson, PS; Wyatt, I1
Kahn, RA; Panah, M; Weinberger, J1
Aoyama, K; Matsumura, N; Nakaki, T; Watabe, M1
Baskaran, P; Beuve, A; Heckler, EJ; van den Akker, F1
Chen, L; Conway, CM; Dubowchik, GM; Luo, G; Macor, JE; Pin, SS; Xu, C1
Jin, X; Lv, H; Zhang, Z; Zhou, J1

Other Studies

7 other study(ies) available for aspartic acid and indazoles

ArticleYear
Contemporary possibilities of medicamentous prevention of cataract.
    Acta medica Iugoslavica, 1990, Volume: 44, Issue:4

    Topics: Adult; Aged; Aspartic Acid; Cataract; Drug Combinations; Female; Humans; Indazoles; Inosine Monophosphate; Male; Middle Aged; Niacinamide; Parabens; Thimerosal; Visual Acuity

1990
Possible role of nitric oxide in the development of L-2-chloropropionic acid-induced cerebellar granule cell necrosis.
    British journal of pharmacology, 1996, Volume: 117, Issue:8

    Topics: Animals; Aspartic Acid; Cerebellum; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Hydrocarbons, Chlorinated; In Vitro Techniques; Indazoles; Male; Necrosis; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitroarginine; Ornithine; Propionates; Rats

1996
Modulation of ischemic excitatory neurotransmitter and gamma-aminobutyric acid release during global temporary cerebral ischemia by selective neuronal nitric oxide synthase inhibition.
    Anesthesia and analgesia, 1997, Volume: 84, Issue:5

    Topics: Animals; Aspartic Acid; Brain; Brain Ischemia; Excitatory Amino Acids; gamma-Aminobutyric Acid; Glutamic Acid; Glycine; Indazoles; Male; Microdialysis; Neurons; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley

1997
Oxidative stress on EAAC1 is involved in MPTP-induced glutathione depletion and motor dysfunction.
    The European journal of neuroscience, 2008, Volume: 27, Issue:1

    Topics: 1-Methyl-4-phenylpyridinium; Acetylcysteine; Animals; Aspartic Acid; Behavior, Animal; Cysteine; Disease Models, Animal; Drug Interactions; Excitatory Amino Acid Transporter 1; Free Radical Scavengers; Glutathione; Humans; Hydrogen Peroxide; Hydroxamic Acids; In Vitro Techniques; Indazoles; Male; Mice; Mice, Inbred C57BL; Movement Disorders; MPTP Poisoning; Neuroprotective Agents; Oxidative Stress; Substantia Nigra

2008
Aspartate 102 in the heme domain of soluble guanylyl cyclase has a key role in NO activation.
    Biochemistry, 2011, May-24, Volume: 50, Issue:20

    Topics: Alanine; Animals; Aspartic Acid; Chlorocebus aethiops; COS Cells; Enzyme Activation; Guanylate Cyclase; Heme; Indazoles; Models, Molecular; Mutagenesis, Site-Directed; Mutation; Nitric Oxide; Protein Structure, Tertiary; Protein Subunits; Rats; Receptors, Cytoplasmic and Nuclear; Sequence Homology, Amino Acid; Soluble Guanylyl Cyclase

2011
Calcitonin gene-related peptide (CGRP) receptor antagonists: novel aspartates and succinates.
    Bioorganic & medicinal chemistry letters, 2012, Apr-15, Volume: 22, Issue:8

    Topics: Aspartic Acid; Calcitonin Gene-Related Peptide Receptor Antagonists; Humans; Indazoles; Inhibitory Concentration 50; Molecular Structure; Protein Binding; Quinazolinones; Stereoisomerism; Structure-Activity Relationship; Succinates

2012
Doxorubicin combined with betulinic acid or lonidamine in RGD ligand-targeted pH-sensitive micellar system for ovarian cancer treatment.
    International journal of pharmaceutics, 2019, Nov-25, Volume: 571

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Arginine; Aspartic Acid; Betulinic Acid; Cell Line, Tumor; Doxorubicin; Drug Carriers; Drug Compounding; Drug Liberation; Female; Glycine; Humans; Hydrogen-Ion Concentration; Indazoles; Leukocyte Count; Ligands; Mice; Micelles; Oligopeptides; Ovarian Neoplasms; Pentacyclic Triterpenes; Tissue Distribution; Triterpenes; Xenograft Model Antitumor Assays

2019